Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors
Clinical trial NCT03891706 · RECRUITING
Trial details
- NCT number
- NCT03891706
- Sponsor
- Guangzhou FineImmune Biotechnology Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2025-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.